HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

REACH Pre-Registration Opens In June; Firms Advised To Begin Amassing Data

This article was originally published in The Rose Sheet

Executive Summary

Although the first registration deadline for phase-in substances is not until 2010, companies subject to Registration, Evaluation, Authorization and Restriction of Chemicals law in Europe should start compiling relevant data now, speakers at an April 14 REACH workshop in Brussels, Belgium, said

You may also be interested in...



REACH Pre-Registration Window Closing; Who Will Be Left Out In The Cold?

With the window for REACH pre-registration closing Dec. 1, companies operating under the impression that they are unaffected by the European chemicals law may be in for a rude awakening, according to Mindy S. Goldstein, executive director of R&D at The Estee Lauder Companies

REACH Pre-Registration Window Closing; Who Will Be Left Out In The Cold?

With the window for REACH pre-registration closing Dec. 1, companies operating under the impression that they are unaffected by the European chemicals law may be in for a rude awakening, according to Mindy S. Goldstein, executive director of R&D at The Estee Lauder Companies

Major U.S. Cosmetic Firms Say They Are Ready For Animal Test Ban In EU

The EU's upcoming ban on products tested on animals could affect the availability of some novel cosmetic ingredients, though it is unlikely to have a jarring impact on large U.S. personal-care marketers

Related Content

UsernamePublicRestriction

Register

RS015380

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel